David Charles Baker - 14 May 2021 Form 4 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role
Chief Executive Officer, Director
Signature
/s/ David Baker
Issuer symbol
GRI
Transactions as of
14 May 2021
Net transactions value
$0
Form type
4
Filing time
18 May 2021, 16:06:03 UTC
Next filing
01 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRI Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 14 May 2021 Common Stock 100,000 $3.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 12 equal quarterly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant.